These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32153734)

  • 21. A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma.
    Wagner J; Pfannenstiel V; Waldmann A; Bergs JWJ; Brill B; Huenecke S; Klingebiel T; Rödel F; Buchholz CJ; Wels WS; Bader P; Ullrich E
    Front Immunol; 2017; 8():676. PubMed ID: 28659917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor effects of NK cells expanded by activation pre‑processing of autologous feeder cells before irradiation in colorectal cancer.
    Koh EK; Lee HR; Son WC; Park GY; Bae J; Park YS
    Oncol Lett; 2023 Jun; 25(6):232. PubMed ID: 37153058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Innate-Immune-Cell-Based Immunotherapy for Adult T-Cell Leukemia-Lymphoma.
    Nakashima M; Tanaka Y; Okamura H; Kato T; Imaizumi Y; Nagai K; Miyazaki Y; Murota H
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody.
    Lee HR; Son CH; Koh EK; Bae JH; Kang CD; Yang K; Park YS
    Sci Rep; 2017 Sep; 7(1):11075. PubMed ID: 28894091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers.
    Kim EK; Ahn YO; Kim S; Kim TM; Keam B; Heo DS
    Cytotherapy; 2013 Feb; 15(2):231-241.e1. PubMed ID: 23321334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human IL-15 Inhibits NK Cells Specific for Human NK-92 Cells.
    Bergman H; Lindqvist C
    Anticancer Res; 2021 Jul; 41(7):3281-3285. PubMed ID: 34230122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment.
    Oyer JL; Pandey V; Igarashi RY; Somanchi SS; Zakari A; Solh M; Lee DA; Altomare DA; Copik AJ
    Cytotherapy; 2016 May; 18(5):653-63. PubMed ID: 27059202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GMP-compliant, large-scale expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells in vitro and in vivo.
    Lim O; Lee Y; Chung H; Her JH; Kang SM; Jung MY; Min B; Shin H; Kim TM; Heo DS; Hwang YK; Shin EC
    PLoS One; 2013; 8(1):e53611. PubMed ID: 23326467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of Irradiated Peripheral Blood Mononuclear Cells on Both
    Delso-Vallejo M; Kollet J; Koehl U; Huppert V
    Front Immunol; 2017; 8():854. PubMed ID: 28791015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy.
    Maia A; Tarannum M; Lérias JR; Piccinelli S; Borrego LM; Maeurer M; Romee R; Castillo-Martin M
    Cells; 2024 Mar; 13(5):. PubMed ID: 38474415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A New Ex Vivo Method for Effective Expansion and Activation of Human Natural Killer Cells for Anti-Tumor Immunotherapy.
    Yang H; Tang R; Li J; Liu Y; Ye L; Shao D; Jin M; Huang Q; Shi J
    Cell Biochem Biophys; 2015 Dec; 73(3):723-9. PubMed ID: 27259316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer.
    Choi JW; Lee ES; Kim SY; Park SI; Oh S; Kang JH; Ryu HA; Lee S
    BMC Cancer; 2019 Aug; 19(1):817. PubMed ID: 31426763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of dendritic cells on expansion and function of autologous natural killer cells in vitro].
    Li J; Zhao CT; Meng DM; Sun PP; Yang J; Chen B; Zhao XD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):898-902. PubMed ID: 18718086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expansion and activation of natural killer cells from PBMC for immunotherapy of hepatocellular carcinoma.
    Peng BG; Liang LJ; He Q; Huang JF; Lu MD
    World J Gastroenterol; 2004 Jul; 10(14):2119-23. PubMed ID: 15237448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation of highly cytotoxic natural killer cells for treatment of acute myelogenous leukemia using a feeder-free, particle-based approach.
    Oyer JL; Igarashi RY; Kulikowski AR; Colosimo DA; Solh MM; Zakari A; Khaled YA; Altomare DA; Copik AJ
    Biol Blood Marrow Transplant; 2015 Apr; 21(4):632-9. PubMed ID: 25576425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission.
    Torelli GF; Guarini A; Maggio R; Alfieri C; Vitale A; Foà R
    Haematologica; 2005 Jun; 90(6):785-92. PubMed ID: 15951291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depressed ability of patients with melanoma or renal cell carcinoma to generate adherent lymphokine-activated killer cells.
    Sedlmayr P; Rabinowich H; Elder EM; Ernstoff MS; Kirkwood JM; Herberman RB; Whiteside TL
    J Immunother (1991); 1991 Oct; 10(5):336-46. PubMed ID: 1790141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Highly efficient IL-21 and feeder cell-driven
    Granzin M; Stojanovic A; Miller M; Childs R; Huppert V; Cerwenka A
    Oncoimmunology; 2016; 5(9):e1219007. PubMed ID: 27757317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimization of Large-Scale Expansion and Cryopreservation of Human Natural Killer Cells for Anti-Tumor Therapy.
    Min B; Choi H; Her JH; Jung MY; Kim HJ; Jung MY; Lee EK; Cho SY; Hwang YK; Shin EC
    Immune Netw; 2018 Aug; 18(4):e31. PubMed ID: 30181919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome.
    Cifaldi L; Prencipe G; Caiello I; Bracaglia C; Locatelli F; De Benedetti F; Strippoli R
    Arthritis Rheumatol; 2015 Nov; 67(11):3037-46. PubMed ID: 26251193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.